Form EFFECT Clearside Biomedical,
| UNITED STATES | |
| SECURITIES AND EXCHANGE COMMISSION | |
| Washington, D.C. 20549 | |
| Notice of Effectiveness | |
| Effectiveness Date: | December 16, 2025 |
| Accession Number: | 0001193125-25-319171 | ||||||
| Submission Type: | POS AM | ||||||
| |||||||
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- ONWARD Medical to Announce Third-Quarter 2026 Results on November 3, 2026
- Singmed Wraps Up ALLPACK Indonesia 2026, Connecting Global Markets Through Device Innovation and Precision Engineering
- iSpring Launches the BRO900 Seawater Desalination System to Deliver Reliable Fresh water at Sea
Create E-mail Alert Related Categories
SEC FilingsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!





Tweet
Share